Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Regional Inspector General at Department of Health & Human Services
Dave Tawes is a Regional Inspector General in the Office of Evaluation and Inspections, a component within the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS). OEI conducts national evaluations that focus on the prevention of fraud, waste, and abuse in programs administered by HHS. Mr. Tawes joined OEI as analyst in 1997, and has since contributed to more than 50 studies involving Medicare and Medicaid prescription drug issues, including AWP reform, the Medicaid drug rebate program, end-stage renal disease drug pricing, and Federal upper limits. He also plays a key role in OEI’s workplanning efforts for future prescription drug studies.